文献速递妇科

生殖性状对子宫平滑肌瘤风险的遗传贡献:一项大规模全基因组跨性状分析

Genetic contribution of reproductive traits to risk of uterine leiomyomata: a large-scale, genome-wide, cross-trait analysis.
PubMed 文献 · Am J Obstet Gynecol · 2024-01-06

本研究利用欧洲血统女性的大规模全基因组关联研究数据,对初潮年龄、自然绝经年龄、首次生育年龄与子宫平滑肌瘤进行全基因组跨性状分析,发现显著的全局遗传相关性、23个共享位点及孟德尔随机化提示的因果关联,反向因果关联未发现。

要点

  • 子宫平滑肌瘤与初潮年龄(rg=-0.17)、自然绝经年龄(rg=0.23)、首次生育年龄(rg=-0.16)存在显著全局遗传相关。
  • 跨性状荟萃分析识别23个共享位点,其中3个为新位点;转录组关联研究找到15个共享基因。
  • 孟德尔随机化提示遗传预测的初潮年龄较大(OR=0.88)或首次生育年龄较大(OR=0.95)与子宫平滑肌瘤风险降低相关,自然绝经年龄较大(OR=1.08)与风险增加相关。

核心结论

  • 生殖性状与子宫平滑肌瘤之间存在大量共享遗传影响和推定的因果关联。
  • 研究结果提示早期识别女性生殖风险因素可能有助于启动改变潜在子宫平滑肌瘤风险的策略。

研究设计与样本

  • 采用欧洲血统女性的全基因组关联研究数据:初潮年龄(n=329,345)、自然绝经年龄(n=201,323)、首次生育年龄(n=418,758)、子宫平滑肌瘤(病例/对照=35,474/267,505)。
  • 进行综合性的全基因组跨性状分析,系统检查生殖性状与子宫平滑肌瘤之间的共同遗传影响。

主要发现

  • 子宫平滑肌瘤与初潮年龄(rg=-0.17;P=3.65×10-10)、自然绝经年龄(rg=0.23;P=3.26×10-07)、首次生育年龄(rg=-0.16;P=1.96×10-06)存在显著全局遗传相关。
  • 13个基因组区域对自然绝经年龄与子宫平滑肌瘤的局部遗传相关有显著贡献(P<.05/2353)。
  • 跨性状荟萃分析识别23个共享位点,其中3个为新位点;转录组关联研究找到15个共享基因,靶向消化、外分泌或内分泌、神经和心血管系统组织。
  • 孟德尔随机化提示遗传预测的初潮年龄较大(OR=0.88;95%CI 0.85-0.92;P=1.50×10-10)或首次生育年龄较大(OR=0.95;95%CI 0.90-0.99;P=.02)与子宫平滑肌瘤风险降低相关,遗传预测的自然绝经年龄较大与风险增加相关(OR=1.08;95%CI 1.06-1.09;P=2.30×10-27)。
  • 未发现反向因果关联。

临床怎么用

  • 原文结论指出早期识别女性生殖风险因素可能有助于启动改变潜在子宫平滑肌瘤风险的策略。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although phenotypic associations between female reproductive characteristics and uterine leiomyomata have long been observed in epidemiologic investigations, the shared genetic architecture underlying these complex phenotypes remains unclear. OBJECTIVE: We aimed to investigate the shared genetic basis, pleiotropic effects, and potential causal relationships underlying reproductive traits (age at menarche, age at natural menopause, and age at first birth) and uterine leiomyomata. STUDY DESIGN: With the use of large-scale, genome-wide association studies conducted among women of European ancestry for age at menarche (n=329,345), age at natural menopause (n=201,323), age at first birth (n=418,758), and uterine leiomyomata (ncases/ncontrols=35,474/267,505), we performed a comprehensive, genome-wide, cross-trait analysis to examine systematically the common genetic influences between reproductive traits and uterine leiomyomata. RESULTS: Significant global genetic correlations were identified between uterine leiomyomata and age at menarche (rg, -0.17; P=3.65×10-10), age at natural menopause (rg, 0.23; P=3.26×10-07), and age at first birth (rg, -0.16; P=1.96×10-06). Thirteen genomic regions were further revealed as contributing significant local correlations (P<.05/2353) to age at natural menopause and uterine leiomyomata. A cross-trait meta-analysis identified 23 shared loci, 3 of which were novel. A transcriptome-wide association study found 15 shared genes that target tissues of the digestive, exo- or endocrine, nervous, and cardiovascular systems. Mendelian randomization suggested causal relationships between a genetically predicted older age at menarche (odds ratio, 0.88; 95% confidence interval, 0.85-0.92; P=1.50×10-10) or older age at first birth (odds ratio, 0.95; 95% confidence interval, 0.90-0.99; P=.02) and a reduced risk for uterine leiomyomata and between a genetically predicted older age at natural menopause and an increased risk for uterine leiomyomata (odds ratio, 1.08; 95% confidence interval, 1.06-1.09; P=2.30×10-27). No causal association in the reverse direction was found. CONCLUSION: Our work highlights that there are substantial shared genetic influences and putative causal links that underlie reproductive traits and uterine leiomyomata. The findings suggest that early identification of female reproductive risk factors may facilitate the initiation of strategies to modify potential uterine leiomyomata risk.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Xiao C, Wu X, Gallagher CS, et al. Genetic contribution of reproductive traits to risk of uterine leiomyomata: a large-scale, genome-wide, cross-trait analysis. Am J Obstet Gynecol. 2024. PMID: 38191017. doi:10.1016/j.ajog.2023.12.040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。